Lenacapavir is a long-acting pre-exposure prophylaxis (PrEP) product, a treatment that works by stopping HIV from getting ...

An analysis by Li Tao, MD, MS, PhD, director of real-world evidence at Gilead Sciences, and colleagues looked at statistical ...

Indigenous communities in Latin America say they are missing out on life-saving HIV drugs due to a lack of representation.

Harmony Garges, M.D, senior vice president, chief medical officer and head of global medical at ViiV Healthcare, highlighted ...

Domestically, I hope to see a focus on expanding access to PrEP, including newer injectable formulations; combating stigma, discrimination, and violence faced by people living with HIV and key ...

HIV groups have criticised a decision not to recommend a long-acting injectable form of PrEP (Pre-exposure prophylaxis ... (NICE), the body that publishes guidelines on which treatments should ...

HIV groups have criticised a decision not to recommend a long-acting injectable form of PrEP (Pre-exposure prophylaxis ... for Health and Care Excellence (NICE), the body that publishes guidelines on ...

They examined annual PrEP uptake, discontinuation, and other HIV prevention measures in a cohort of TMSM ... that studies focus on this community as a primary stakeholder, and that clinical guidelines ...

The increasing incidence of sexually transmitted bacterial infections (STIs) is a major public health problem worldwide.

This study was conducted following the Brazilian and international research ethics guidelines ... as a follow-up with their PrEP pills 2020Dourado I, Magno L, Soares F, et al. Adapting to the COVID-19 ...